News
Amplify BlueStar Israel Technology ETF Stock Down 0.1 % Shares of ITEQ stock opened at $44.81 on Tuesday. The company has a market cap of $78.42 million, a P/E ratio of 27.91 and a beta of 1.08 ...
On the heels of a recent cost-cutting drive that severed much of AmplifyBio’s R&D capacity, the Ohio-based contract manufacturing and research hybrid has hung up its hat for good. Amplify’s ...
Honda will send its fuel-cell technology to the International Space Station to develop a closed-loop energy and sustainability system to support life in space and on the moon. “The project is ...
AGC Biologics announces a new dedicated Cell and Gene Technologies Division, providing resources for this market lacking technical CDMO expertise. AGC Biologics is investing and growing in a ...
Renier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers ...
By expanding its high-power RF amplifier technology offerings, Frontgrade is taking action to enhance its capabilities and address the complex and evolving challenges faced by the aerospace and ...
Attendees will gain access to key updates on the HP Amplify Partner Program, the latest AI-powered technologies showcased throughout an impressive 40,000 square foot exhibit, and an exciting first ...
known as the Cell Shuttle, has received a coveted advanced manufacturing technology (AMT) designation from the FDA’s Center for Biologics Evaluation and Research, the company announced this week.
Attendees will gain access to key updates on the HP Amplify Partner Program, the latest AI-powered technologies showcased throughout an impressive 40,000 square foot exhibit, and an exciting first ...
The same genes could hold the key to regenerating cells in the ear and eye, according to a new mouse study from the USC Stem Cell laboratory of Ksenia Gnedeva, PhD, published in the Proceedings of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results